BAFNA PHARMACEUTICALS
Back to Balance Sheet
|
BAFNA PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹52 Cr | ₹54 Cr | ₹46 Cr | ₹22 Cr | ₹24 Cr |
What is the latest Total Current Liabilities ratio of BAFNA PHARMACEUTICALS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹52 Cr |
| Mar2024 | ₹54 Cr |
| Mar2023 | ₹46 Cr |
| Mar2022 | ₹22 Cr |
| Mar2021 | ₹24 Cr |
How is Total Current Liabilities of BAFNA PHARMACEUTICALS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹52 Cr | -4.13 | |
| Mar2024 | ₹54 Cr | 16.37 | |
| Mar2023 | ₹46 Cr | 111.13 | |
| Mar2022 | ₹22 Cr | -9.45 | |
| Mar2021 | ₹24 Cr | - | |
Compare Total Current Liabilities of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹688.2 Cr | 12% | 10% | 209.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹460,696.0 Cr | 0.5% | -4% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,063.0 Cr | 9.1% | 18.2% | 47.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,515.0 Cr | 3.6% | 3.4% | 36.4% | Stock Analytics | |
| CIPLA | ₹114,554.0 Cr | -1.2% | -3.3% | -10.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,308.6 Cr | -1.4% | 2.9% | -8% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | 12% |
10% |
209.1% |
| SENSEX | -0.4% |
-0.5% |
-5.8% |
You may also like the below Video Courses